Targeting dual specificity protein kinase TTK attenuates tumorigenesis of glioblastoma

Area of Science:

• Oncology
• Molecular Biology
• Cancer Stem Cell Research

Background:

• Glioma stem-like cells (GSCs) drive glioblastoma (GBM) initiation, resistance, and recurrence.
• Identifying key regulators of GSCs is crucial for developing effective GBM therapies.

Purpose of the Study:

• To identify novel therapeutic targets in glioblastoma by investigating GSC-specific molecular alterations.
• To elucidate the role of dual specificity protein kinase TTK (TTK) in GSC maintenance and GBM progression.

Main Methods:

• Differential gene expression analysis in GSCs and non-GSC GBM cells.
• Functional assays for clonogenicity and tumor propagation in vitro and in vivo.
• Correlation analysis of TTK expression with clinical GBM patient data.
• Investigation of the regulatory relationship between TTK and mitochondrial fission regulator 2 (MTFR2).

Main Results:

• TTK was identified as the most upregulated kinase gene in GSCs.
• TTK is essential for GSC clonogenicity and in vivo tumor propagation.
• High TTK expression in GBM correlates with poor patient prognosis.
• MTFR2 transcriptionally activates TTK, playing a key role in GSC maintenance.

Conclusions:

• The MTFR2-TTK axis is critical for maintaining GSCs in GBM.
• Targeting TTK, regulated by MTFR2, represents a promising therapeutic strategy for GBM.